Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Drug discovery and development business31.31B67.09%
Radioactive pharmaceutical business16.1B34.50%
Adjustment amount-740.69M-1.59%
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
Europe29.38B62.94%
Japan15.57B33.35%
United States1.42B3.04%
Others311.48M0.67%